Articles and Videos
Loading...
November 23, 2021
InMed welcomes the BayMedica team! Meet Shane Johnson, SVP and General Manager
InMed Pharmaceuticals is pleased to welcome the BayMedica team following its acquisition in October 2021. Meet Shane Johnson, our Senior Vice President and General Manager....
Source: Edison TV
November 16, 2021
InMed welcomes the BayMedica team! Meet Chris Meiering, VP of Commercial Operations
InMed Pharmaceuticals is pleased to welcome the BayMedica team following the acquisition in October 2021. Meet Chris Meiering, our VP of Commercial Operations. Chris talks...
Source: Edison TV
November 8, 2021
The Dales Report Interview: InMed Pharmaceuticals Makes Noise With Patent Application & Acquisition: Cannabis Stock Investing
Shadd Dales of The Dales Report asks InMed CEO, Eric A. Adams, about the recent news of InMed’s patent application for a cannabinoid treatment targeting...
Source: The Dales Report
October 28, 2021
InMed’s Shane Johnson Speaks at Edison Open Forum Cannabinoids 2021
Shane Johnson, InMed’s Senior VP and BayMedica’s General Manager, joins the Edison Open Forum Cannabinoids 2021 Event. In his interview, Shane talks about InMed and...
Source: Edison
October 28, 2021
InMed Pharmaceuticals Presents at 2021 Benzinga Cannabis Capital Conference
InMed's President and CEO, Eric A. Adams, presents at the 2021 Benzinga Cannabis Capital Conference from October 14-15. In this presentation, Mr. Adams talks about...
Source: Benzinga
October 6, 2021
Benzinga: Pharmaceutical Cannabinoids and their Impact on Treatments for Complex Diseases
InMed's Senior VP, Preclinical Research and Development, Dr. Eric Hsu, join the Benzinga Small Cap Conference Panel Discussion "Pharmaceutical Cannabinoids and their Impact on Treatments...
Source: Benzinga
